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Abstract: Physical activity is associated with a favourable (blunted) cortisol stress reactivity in
healthy people. However, evidence from experimental study and with psychiatric patients is missing.
This study examines whether exercise training impacts on cortisol stress reactivity in inpatients with
major depressive disorder (MDD). These new insights are important because the stress reactivity of
healthy people and patients with severe symptoms of depression might differ. Methods: The study
was designed as a randomized controlled trial (trial registration number: NCT02679053). In total,
25 patients (13 women, 12 men, mean age: 38.1 ± 12.0 years) completed a laboratory stressor task
before and after a six-week intervention period. Nine samples of salivary free cortisol were taken
before and after the Trier social stress test (TSST). Fourteen participants took part in six weeks of
aerobic exercise training, while 11 patients were allocated to the control condition. While the primary
outcome of the study was depressive symptom severity, the focus of this paper is on one of the
secondary outcomes (cortisol reactivity during the TSST). The impact of aerobic exercise training
was examined with a repeated-measures analysis of variance. We also examined the association
between change in depression and cortisol response via correlational analysis. Cortisol reactivity
did not change from baseline to post-intervention, either in the intervention or the control group.
Participation in six weeks of aerobic exercise training was not associated with participants’ cortisol
reactivity. Moreover, depressive symptom change was not associated with change in cortisol response.
Aerobic exercise training was not associated with patients’ stress reactivity in this study. Because many
patients initially showed a relatively flat/blunted cortisol response curve, efforts might be needed to
find out which treatments are most efficient to promote a normalization of HPA axis reactivity.
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J. Clin. Med. 2020, 9, 1419; doi:10.3390/jcm9051419 www.mdpi.com/journal/jcm
J. Clin. Med. 2020, 9, 1419 2 of 23
1. Introduction
Major depression is among the most common and burdensome disorders worldwide.
In Switzerland [1], as in other Western countries [2], more than 20% of the population are affected
by major depression once in a lifetime. Currently, major depressive disorders (MDDs) constitute the
leading cause of years lived with disability (YLDs) [3] and in 2030, MDDs are expected to cause the
greatest number of disability-adjusted life years (DALYs) [4].
Depression is often referred to as a stress-related disorder [5]. In line with this notion, exposure
to critical life events and chronic stress play an important role in the onset and course of MDDs [6].
Accordingly, most individuals who develop a depressive episode experience a major adverse life
event before depression onset [7]. Chronic stress exposure also increases the risk of developing a new
depressive disorder [8]. Moreover, scholars have highlighted that people with depressive disorders are
more likely to perceive their lives as stressful [9].
The relationship between stress and depressive disorders has often been attributed to
a dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis [10,11], and it is expected that
a normalization of HPA axis activity will lead to an improvement in depressive symptom severity [12,13].
In line with this notion, previous studies have shown that chronically high stress levels are associated
with a dysregulated diurnal HPA axis activity [14], an increased cortisol awakening response [15], and
an increased reactivity in response to experimentally induced stress [16,17]. Similarly, evidence suggests
that MDD might be associated with a dysregulation of HPA axis activity [18]. For instance, researchers
observed a hyperactivity of the HPA axis and a lower suppression of cortisol after a dexamethasone
suppression test (DST) among individuals with MDD [19–21]. Nevertheless, findings have not always
been consistent [20]. For instance, in a systematic review and meta-analysis with 20 case-control
studies, Knorr et al. [22] were unable to detect a clear difference in diurnal salivary cortisol levels
between depressed patients and non-depressed controls, and some studies found that patients might
even have lower cortisol levels [23,24]. The latter has been interpreted as an indication of HPA axis
exhaustion, following chronic or recurrent depression [23,24].
Researchers have also tested whether people with depression differ from non-depressed
counterparts with regard to their stress reactivity. If exposed to an acute stressor, healthy people
generally show a dynamic and responsive pattern of cortisol secretion, with stress reactivity typically
peaking 20 to 40 min after onset of the stressor [25]. In previous research, different patterns of
cortisol secretion were found between depressed and non-depressed participants when they were
exposed to an experimentally induced psychosocial stressor task [26]. However, the pattern seems
to be moderated by a variety of factors, including participants’ age. Thus, in child and adolescent
samples, no clear pattern emerged. While depressed participants exhibited a higher cortisol reactivity
and a delay in cortisol recovery in some studies [27,28], the findings of other investigations pointed
towards a blunted cortisol reaction [29,30]. Among adults, a meta-analysis indicated a similar cortisol
reactivity, but higher pre-stress cortisol levels and increased cortisol levels during the recovery period
in clinically depressed individuals compared to non-depressed individuals [31]. A more recent
meta-analysis [32] with 12 studies focusing on HPA axis responses to the Trier social stress test
(TSST: 33) (or comparable distressing paradigms) confirmed that depressed participants showed
a reactivity pattern similar to that of healthy controls, after controlling for cortisol levels prior to the
TSST. However, the meta-analysis of Burke et al. [31] suggested that stress reactivity might depend
on depression severity since participants with more severe depressive symptoms tended to show
a reduced cortisol response (flat and unresponsive pattern of cortisol secretion) in response to laboratory
stress. The notion of a blunted cortisol reactivity is in line with other experimental and naturalistic
studies [32–36]. In summary, previous research suggests that the cortisol reactivity of people with
depressive disorders may differ from healthy individuals, however these differences seem to depend
on several extraneous factors. Lopez-Duran et al. [37] argued that a larger variability in stress reactivity
might exist in depressed participants than healthy controls, which is in line with Peeters et al. [38],
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who observed a higher variability in circadian cortisol secretion among patients with MDDs compared
to healthy controls, if participants were assessed in their everyday environment.
Meanwhile, scholars have identified several sources of individual variability in stress reactivity [39].
One such factor is participants’ physical activity and fitness level. As shown in a recent systematic
review [40], about 60% of all existing studies suggest that higher physical activity and fitness levels
are associated with an attenuated cortisol response to the TSST, one of the most widely used and
validated laboratory stressors [25]. However, Mücke et al. [40] also showed that most evidence is
based on cross-sectional observations, whereas longitudinal and experimental studies are lacking.
The impact of physical activity and fitness on adrenocortical activity has been explained with the
so-called cross-stressor-adaptation (CSA) hypothesis [41]. This hypothesis suggests that exposure
to physical stress (e.g., vigorous exercise) elicits a comparable stress reaction as the one following
exposure to psychosocial stressors. With other words, the CSA posits that the (favourable) adaptations
of HPA axis activity due to regular exercise participation generalize to situations where people are
confronted with other, non-physical (e.g., cognitive or psychosocial) stressors. So far, however, only
one experimental study has been carried out to test the CSA, with the TSST as an experimental stress
trigger [42]. In this study, physically inactive (but generally healthy) male office workers recruited from
banking and insurance companies were assigned to a 12-week running training program or a wait-list
control condition. The findings of this study show that the cortisol stress reactivity decreased from
pre- to post-intervention in the running group, which was not the case in the wait-list control group.
While this study indicates that regular exercise training may indeed lead to a reduced stress reactivity,
it is premature to draw firm conclusions about cause and effect until more experimental evidence
has been collected. In view of the potential differences between healthy people and individuals
suffering from MDDs, it also remains unclear whether these findings can be generalized to other
(less healthy) populations.
A better understanding of whether such a generalization is possible seems important for several
reasons: First, recent meta-analyses have shown that exercise training has the potential to decrease
symptom severity [43–49] and to improve physical fitness [50] among patients suffering from mild to
more severe depression. Second, findings from single trials suggest that exercise training may have
effects comparable to those of pharmacological treatment [51], that exercise training has a positive
impact if used as an add-on to standard care (compared with standard care alone) [52], and that even
treatment-resistant patients might benefit from regular exercise training [53]. Third, researchers have
shown increasing interest in the neurobiological mechanisms that may explain the benefits of exercise
training in individuals with MDD [54,55]. For instance, Schuch et al. [54] recently argued that the
benefits associated with exercise might be due to both acute and chronic effects, and be attributable to
a variety of mediating factors including atrial natriuretic peptide, brain natriuretic peptide, copeptin,
cortisol, growth hormone, prolactin, brain-derived neurotrophic factor, insulin like growth factor 1,
vascular endothelial growth factor, pro-inflammatory cytokines, anti-inflammatory cytokines, oxidative
stress, and changes on cortical structure and activity. In their review, Kandola et al. [55] also identified
neuroendocrine response, neuroplasticity, inflammation and oxidative stress as the main underlying
biological mechanisms. With regard to the neuroendocrine response, Kandola et al. [55] argued that
prolonged and excessive cortisol exposure can have neurotoxic effects, lead to unfavourable changes of
brain structures, and to cognitive deficits that are linked with depression. Accordingly, they conclude
that “interventions that normalise HPA axis tone may minimise the corresponding neural harms and
support the treatment of depression” (p. 529). This is in line with Matta Mello Portugal et al. [56] and
Wegener et al. [57], who suggest that exercise training might result in precisely such a normalisation of
the HPA axis activity.
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Despite this, the evidence regarding the question of whether exercise leads to neuroendocrine
adaptations in patients with MDD is still very limited. Kiive et al. [58] observed no differences with
regard to the initial cortisol levels and responses to an incremental bicycle ergometer test between
clinically depressed patients and healthy controls. This was partly corroborated by Krogh et al. [59],
who found that resting plasma levels of cortisol did not differ between clinically depressed patients and
healthy controls. However, their findings indicated that depressed patients showed a blunted cortisol
response during an incremental bicycle ergometer test. Ida et al. [60] found that saliva free cortisol
levels decreased after a single 15-min aerobic exercise session among depressed patients; and this
decrease was accompanied by an improvement of subjective depressive symptoms. Krogh et al. [59]
further reported that changes in cortisol levels did not differ between patients assigned to either
12-week exercise training or an active control condition (relaxation exercises). Nevertheless, this
contrasts with a study by Foley et al. [61], who found that 12 weeks of aerobic exercise training resulted
in a decreased cortisol awakening response (CAR), whereas the active control condition (stretching)
was associated with an increased CAR. This is in line with the findings of Krogh et al. [59], who
observed a significant decrease in the stress hormone copeptin [62] in the aerobic exercise condition
(compared to the active control), particularly among patients with high compliance to the exercise
intervention [63].
Taken together, an inadequate cortisol secretion as a consequence of a disturbed HPA axis activity
seems to play an important role in the onset and maintenance of MDD [64]. Cortisol is considered
as a mediating factor linking chronic psychosocial stress with depression [5]. Although chronic
stress and exercise both trigger a cortisol response [65,66], chronic stress has a detrimental effect on
cognition, neural plasticity and well-being, whereas exercise seems to have a beneficial impact [67].
It is therefore possible that both acute and chronic exercise might contribute to a normalization of
HPA axis activity [56,57]. However, research in patients with MDD is very limited, and results are not
conclusive. Recent reviews therefore collectively come to the conclusion that more research is needed
in this area [54,68,69]. Although the TSST is the most widely used laboratory stressor to experimentally
induce a stress response [70], and previous studies suggest that regular exercise participation might
positively affect the cortisol response to the TSST among healthy people [40,42], the effects of chronic
exercise on the cortisol reactivity in response to the TSST have not yet been tested among patients
with MDD.
Against this background, the main purpose of our study was to test for the first time whether
an exercise intervention has an impact on cortisol stress reactivity in a psychiatric patient population
(inpatients with MDD). Based on the existing body of research, it was not possible to formulate
a clear-cut hypothesis: While the only existing exercise trial with healthy participants indicates that
exercise training results in a blunted cortisol secretion in response to the TSST [42], evidence with
participants with more severe depressive symptoms suggests that this population shows a flat and
unresponsive pattern of cortisol secretion in response to laboratory stress. If the cortisol response is
blunted, it seems unlikely that a further reduction in cortisol response as consequence of exercise training
will be observable. In this case, it might also be that exercise training may lead to a normalization of
cortisol secretion under laboratory stress conditions.
2. Materials and Methods
2.1. Participants and Procedures
Participants were recruited from two (public) psychiatric clinics in the Northwestern,
German-speaking part of Switzerland. The following inclusion criteria were assessed by the consultant
psychiatrist of the respective depression ward as part of the initial screening (in the first week of
hospitalization), prior to providing more specific information about the study to the eligible patients:
(a) aged >18 and <61 years, (b) be an inpatient in one of the two depression wards, (c) ICD-10 diagnosis
of depression (first episode, recurrent or bipolar; F32, F33, F31). Moreover, the following exclusion
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criteria were applied: (a) a score <17 on the Hamilton depression rating scale 17 (HDRS17) at the
baseline data assessment, (b) presence of a somatic condition not permitting regular exercise, (c) body
mass index (BMI) > 35 kg/m2, (d) pregnant at the baseline data assessment, (e) acute suicidal ideation,
(f) comorbid substance dependence (except nicotine), (g) comorbid major psychiatric disorder, and (h)
participation in regular vigorous-intensity exercise (i.e., participating in long distance runs).
The study was designed as a two-centre, two-armed randomised controlled trial (RCT), with a 1:1
allocation ratio (intervention:control group). The study was registered at https://www.clinicaltrials.gov
(trial number: NCT02679053). As highlighted in the study protocol [71], the primary outcome of
this study was depression severity. While the effects of the intervention on the primary outcome are
presented elsewhere [72], the focus of the present paper is on one of the secondary outcomes (cortisol
response during the TSST).
Recruitment took place between October 2013 and January 2016, and was done by the local study
coordinators. A graphical representation of the study schedule including information about which
measurements were performed at which timepoint is presented in the study protocol [71]. As shown in
Figure 1, written informed consent was obtained from all participants that were eligible for the study,
and they were allocated to either an aerobic exercise condition (intervention group) or a standardised
stretching and mobility program (active control group) after the baseline data assessment. The last
author was responsible for the randomisation and assignment of the participants to the intervention
and control group. Simple randomisation was achieved by drawing lots for the intervention and control
condition, separately for males and females. Blinding of patients with regard to group allocation was
achieved by informing them that two different exercise programs were to be compared, but not letting
them know which intervention was considered the intervention or control condition. Data assessors
and local study coordinators were fully blinded to group allocation (by anonymized ID). The baseline
data assessment took place during the first or second week of hospitalization.
To detect a moderate effect (f = 0.25) in the RCT on the primary outcome (depressive symptoms
severity), a power analysis for repeated measures analyses of variance (ANOVAs) (using G*Power 3.1;
alpha error probability: 0.05, power: 0.90, correlations among measures: 0.50) revealed that at least
n = 36 (overall) participants are needed. We therefore originally aimed to include 40 patients with
a roughly equal gender distribution.
Before the beginning of the study, ethical clearance was obtained from the Ethics Committee of
both Basels (EKBB, Basel, Switzerland; reference no. 62/13) and the Ethics Committee Aargau/Solothurn
(Aarau, Switzerland; reference no. 2013/029) and all study procedures were carried out in line with the
ethical principles defined in the 1964 Declaration of Helsinki and its later amendments.
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Figure 1. Participant flow chart.
2.2. Intervention vs. Control Condition
The intervention consisted of supervised aerobic exercise on indoor bicycles three times per
w ek for six consecutive week . The target h artrate (HR) w s set at 60–75% of maximal heartrate
(HRm x) monitored with Pola ™ RS800CX. We used the following formula (220–age (in years)) to
compute HRmax. Following Dunn et al. [73], the targeted exercise-based energy expenditure was
17.5 kcal per kg bodyweight.
Participants assigned to the active control condition, engaged in a program consisting of
coordination and stretching activities for all major muscle groups using a medium strength Theraband®,
a gymnastics ball (diameter 65 cm) and juggling balls, which also took place three times per week for
six co secutive weeks. To ensure that the intensity in the control group was kept at a low level during
the stretching sessions, supervisors reminded the participants of the control group that they should not
get out of breath. This was important to avoid an overlap in activity intensity between the intervention
and the control group. To minimize the influence of social contact, the coordination and stretching
activities were also carried out individually or in groups of two patients.
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All sessions (intervention and active control group) were scheduled in the late afternoon (between
4 and 6 p.m.) for approximately 40–50 min. Additionally, all patients received standard inpatient
treatment consisting of pharmacological treatment according to Swiss national standards [74], individual
and group-psychotherapy supported by an array of creative group therapies. Pharmacological treatment
was limited to antidepressant treatment with selective serotonine-reuptake-inhibitors (SSRI) or selective
serotonine-norepinephrine-reuptake-inhibitors (SNRI) and lithium as augmentation strategy, whereas
antidepressant combination therapy, tricyclic antidepressants, MAO-inhibitors, and antipsychotics
other than low-dose quetiapine for sedation were not allowed. Participants were asked not to engage
in any additional vigorous exercise activities during their stay at the hospital. However, engagement
in additional vigorous exercise was not systematically monitored. Evidence regarding compliance
with the intervention program has been reported previously [71].
2.3. Trier Social Stress Test
We used the Trier Social Stress Test (TSST) [33] to experimentally induce stress. The TSST consists
of two standardised 5-min tasks including a free speech task (job interview) and a mental arithmetic
task (counting backwards in steps of 13 from a 4-digit number). At both measurement occasions,
the TSST was performed in front of a jury of two people unknown to the patient. Patients were
also informed that the test would be videotaped to evaluate their behaviour. Patients had 5 min to
prepare themselves for the speech task, before they entered the test room. The test was completed
in a standing position. After completion of the TSST, participants recovered in a separate room for
a period of 60 min. In the present study, the TSST was carried out exactly at 2 p.m. to control for
circadian variations of cortisol levels [75]. The participants were also asked to refrain from eating,
drinking (except for water) and from any moderate or vigorous intensity physical activity 2 h prior to
the beginning of the stress protocol. While previous research has shown that participation in physical
activity prior to the TSST might have acute effects on stress reactivity [76], researchers also showed
that cortisol levels typically return to the level prior to the TSST within two hours after individual
have stopped exercise participation [77]. All participants were unaware of the experimental protocol.
Because stress reactions depend on the novelty of the stressor task [25], responses might be less strong
if the same psychosocial stressor task is performed a second time [78]. However, researchers showed
that the stressfulness of the TSST can be maintained if the stressor tasks are modified [79]. We therefore
slightly changed the content of the free speech task (application for a promotion/prize) and mental
arithmetic tasks (counting backwards in steps of 13 from a different number), but ensured that the
socio-evaluative pressure of the stressor protocol was maintained. According to Mazurka et al. [80],
the TSST is useful for examining the stress reactivity in depression “because it provokes the HPA axis
response by activating the same corticolimbic circuitry implicated in the pathology of major depression”
( . . . ), whereas “pharmacologic challenge tests and studies of the cortisol awakening response bypass
this important circuitry and directly activate components of the axis” (pp. 301–302).
2.4. Assessment of the Adrenocortical Stress Response
The adrenocortical stress response was measured via salivary cortisol samples. To minimize
an anticipation bias, we gathered the first saliva sample before participants were informed about the
nature of the experimental stress protocol. At both the baseline data assessment and at post-intervention,
salivary cortisol was obtained at−20, −5, +1, +5, +10, +20, +30, +45, and +60 min prior to the onset/after
completion of the TSST, using commercially available devices (Salivette®, Sarstedt, Germany).
All samples were stored at −20 ◦C, before they were sent to the Biochemical Laboratory of the
University of Trier for analyses (approximately every three months). Free salivary cortisol levels
(nmol/L) were established, based on a time-resolved fluorescence immunoassay (for more details
see: [81]).
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2.5. Assessment of Covariates
2.5.1. Depressive Symptom Severity
Symptom severity of depression was measured with the 21-item Beck Depression Inventory [82,83].
The BDI measures a range of affective, behavioural, cognitive, and somatic symptoms, which
are characteristic for unipolar depression (e.g., “I am so unhappy/sad that I can’t stand it.”).
Response options are anchored on a scale from 0 to 3, with higher scores being indicative of stronger
depressive symptomatology. A sum score was calculated to generate an overall index with a potential
range from 0 to 63 and higher scores reflecting more severe depressive symptoms. Scores between 0
and 9 are considered as no depression, whereas scores of 10–18, 19–29, and 30–63 can be interpreted as
mild, moderate and severe depression, respectively. The Cronbach’s alpha in the present sample was
0.72 at baseline.
2.5.2. Physical Activity
To gather information about participants’ physical activity levels prior to hospitalization,
participants filled in a written version of the German International Physical Activity Questionnaire
Short Form (IPAQ-SF) [84]. The IPAQ-SF assesses time spent in moderate physical activity (e.g.,
bicycling at a regular pace, low-intensity sports such as doubles tennis) and vigorous physical activity
(e.g., fast bicycling, running, aerobics), using a frequency-by-duration format. Thus, participants first
reported the number of days per week they engaged in these activities (from 0 to 7 days), and then
indicated the average duration (in minutes) for the days they engaged in these activities. Participants
were asked to refer to the last week prior to admission to the hospital. Multiplication of frequency
and duration scores resulted in an estimate of weekly hours invested in moderate and vigorous
physical activity. Summing up these two scores resulted in a total score for time (in min/week) spent in
moderate-to-vigorous physical activity (MVPA). Evidence for the validity of the IPAQ-SF has been
shown previously in adult samples [85].
2.5.3. Further Potential Confounders
We assessed sex, age, smoking status, educational status, duration of current depressive episode,
number of prior depressive episodes, and age of onset of depression. Additionally, all patients
underwent a physical examination including the assessment of blood pressure (BP), resting heart rate
(HR), as well as body weight and height. Body weight (kg) and height (m) were used to calculate
participants’ body mass index (BMI; kg/m2).
2.6. Statistical Analyses
We first examined whether results of the different variables are normally distributed (using
Kolmogorov–Smirnov and Shapiro–Wilk tests). To examine whether baseline differences existed
between the intervention and control groups, in the case of normally distributed (metric) variables,
ANOVAs were conducted, and descriptive statistics were reported as M and SD. If either the
Kolmogorov–Smirnov or the Shapiro–Wilk test indicated a non-normal distribution of a metric variable,
nonparametric tests were used (independent samples median test (Kruskal–Wallis) and independent
samples Mann–Whitney U Test). Moreover, in case of non-normally distributed (metric) variables,
we reported the median (Mdn) and range (min; max). For categorical variables, we used χ2 tests to
examine group differences, and we reported the number (n) and frequency (%) as descriptive statistics.
To assess bivariate associations between the potential covariates and the cortisol responses at
baseline and post-intervention, correlational analyses were conducted. Pearson’s correlations (r) were
used if covariates were normally distributed. Spearman’s correlations (Rho) were used if covariates
were non-normally distributed. In case of non-normally distributed cortisol values, cortisol scores
were logarithmized to achieve a normal distribution prior to calculating the correlations. Moreover, in
case of categorical covariates, analyses of variance (ANOVAs) was conducted.
J. Clin. Med. 2020, 9, 1419 9 of 23
To examine whether the TSST elicited a significant stress response in the total sample and the
intervention and control groups, a repeated measure analysis of variance (ANOVA) was calculated,
with the factors time (two measures from 20 min prior to the onset of the TSST to 20 min after completion
of the stressor task (peak) and group (intervention vs. control group), and the interaction effect (time
x group). The time point 20 min after completion of the stressor task was chosen as a peak, as most
studies show that cortisol levels tend to increase approximately 20 min after the end of a stressor
task [40]. Again, in case of non-normally distributed cortisol values, the logarithmized scores were
used. We also descriptively analysed how many participants responded to the TSST, hereby following
Petrowski et al. [86] who defined a response to the TSST as a salivary cortisol increase of ≥ 2.5 mmol/L
from prior to the TSST to the individual peak.
As an index of overall cortisol stress reactivity, we calculated the area under the total response
curve with respect to ground (AUCG), by using the trapezoid formula described by Pruessner et al. [87],
including the entire time period from 20 min prior to the onset to 60 min after completion of the TSST.
We did not use the total response curve with respect to increase (AUCI), because this index results in
negative values if the repeated measures are lower than the cortisol level prior to the TSST.
To examine whether six weeks of aerobic exercise training had an effect on participants’ overall
stress reactivity, we employed a repeated measures analysis of covariance (ANCOVA) with AUCG
as an outcome, with the factors time (baseline vs. post-intervention), group (intervention vs. control
group), and the interaction effect (time × group), and controlling for depressive symptom severity,
physical activity and further relevant covariates (age, depressive symptom severity, duration of current
depressive episode, number of prior depressive episodes, age at onset of depression, resting heart
rate, blood pressure, height, weight, BMI, MVPA, sex, smoking status, educational background, and
diagnoses). However, covariates were only considered if they were significantly associated with the
cortisol stress response either at baseline or post-intervention. To interpret the magnitude of the
effects, η2 values were shown for both main and interaction effects. Finally, we calculated a Pearson’s
correlation to examine whether changes in depressive symptom severity were associated with changes
in cortisol response. The level of significance was set at p < 0.05 across all analyses. All tests were
carried with SPSS 24 for Mac (SPSS Inc., Chicago, IL).
3. Results
3.1. Sample Characteristics and Descriptive Statistics
As shown in the participant flow chart (Figure 1), 49 participants (25 women, 24 men,
M = 38.9 years, SD = 11.3) were willing to take part in the study. Thereof, four participants (three
women, one man, M = 33.5 years, SD = 13.2) dropped out before the beginning of the data assessment
(three withdrew consent, one was discharged). Of the remaining 45 participants, 10 participants
(five women, five men, M = 37.0 years, SD = 9.8) were not willing to take part in the experimental
stress test (n = 8) or did not meet the inclusion criteria with regard to depression severity (n = 2). Of the
remaining 35 participants with valid baseline data, nine dropped out before post-intervention due
to the following reasons: early discharge (n = 1), withdrawn consent (n = 4), surgery (n = 2), knee
problems (n = 1), and suicide attempt (n = 1). The attempted suicide was considered as a severe adverse
event and immediately reported to the local ethical review committee. However, since there was no
reason to believe that the suicide attempt was caused by the study intervention, no further actions
were deemed necessary other than a more rigorous assessment of suicidal behaviour prior to study
inclusion. One participant was identified as a univariate outlier because stress reactivity exceeded three
standard deviations around the mean. This person was excluded from all further analyses. Among the
patients who took part in the first TSST assessment, no significant differences were found between
dropouts and study completers in any of the study variables. The post-intervention assessment took
place immediately after completion of the six-week intervention/control period.
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As shown in Table 1, not all (metric) study variables were normally distributed in the present
sample. This is taken into consideration when sample characteristics and descriptive statistics for the
baseline and post-intervention data assessment are presented (Table 1).
On average, the total sample (n = 25) was 38.1 (SD = 12.0) years old, and consisted of 13 women and
12 men. Most of the participants were diagnosed with a first unipolar depressive episode (n = 10, 40%)
or recurrent depressive episode (n = 14, 56%); only one participant (4%) was diagnosed with bipolar
depression. Based on the BDI scores, three participants (12%) reported mild depression, 14 (56%)
reported moderate depression, and eight (32%) reported severe depression. Based on participant
self-reports, five participants (20%) reported that they were completely inactive (0 min/week of
MVPA) prior to hospitalization. Fourteen participants (56%) reported some MVPA, but according
to the standards of the American College of Sports Medicine [88], did not meet current MVPA
recommendations (≥150 min/week). Six participants (24%) accomplished these standards. As shown in
Table 1, no significant baseline differences were found between participants assigned to the intervention
and control group in any of the study variables.
3.2. Reactivity in Response to the TSST at the Baseline Data Assessment
At the baseline data assessment, a repeated measures ANOVA showed that in the total sample,
a significant time effect occurred prior to the onset of the TSST (−20 min) to peak (+20 min after
completion of the TSST), F(2,23) = 4.4, p = 0.046.05, η2 = 0.161, indicating that the TSST elicited a cortisol
response. However, no significant time x group interaction effect was observed, F(2,23) = 0.1, p = 0.769,
η2 = 0.004, and the response curve was flat in both the intervention and control group (see Figure 2).
At the baseline assessment, only a 1.6-fold increase was observed from 20 min prior to the TSST to
peak in the total sample (see Table 1). Moreover, at the baseline data assessment, 52 percent (n = 13) of
the participants responded to the TSST (increase in cortisol from 20 min prior to the TSST to individual
peak of ≥2.5 mmol/l), whereas 48 percent of the participants were classified as non-responders (n = 12).
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Test of between-Group Differences
(ANOVAs)
Metric variables (normally distributed) M SD M SD M SD F p η2
Age 38.1 12.0 39.4 9.7 36.4 14.8 0.39 0.539 0.017
Depressive symptom severity (BDI) at baseline 26.4 8.6 27.6 10.0 24.9 6.6 0.61 0.443 0.026
Depressive symptom severity (BDI) at post-intervention 15.7 11.1 17.1 12.5 14.0 9.2 0.46 0.503 0.020
Age at onset of depression 33.1 12.9 33.8 12.1 32.2 14.5 0.09 0.766 0.004
Resting heart rate (bpm) 75.0 12.8 78.1 14.3 71.0 9.8 1.95 0.176 0.078
Systolic blood pressure (mmHg) 123.9 18.2 128.4 18.9 118.3 16.3 1.97 0.173 0.079
Diastolic blood pressure (mmHg) 75.9 9.9 78.6 7.0 72.4 12.1 1.95 0.176 0.078
Height (cm) 172.1 8.1 171.6 7.4 172.7 9.3 0.12 0.732 0.005
Weight (kg) 71.6 20.3 74.1 22.2 68.4 18.2 0.47 0.500 0.020
BMI (kg/m2) 23.7 4.8 24.7 5.4 22.6 3.8 1.20 0.285 0.050









Duration of current depressive episode 12 3; 52 10 3; 52 13 5; 50 0.202 0.703
Number of prior depressive episodes 1 0; 5 1 0; 5 1 0; 5 0.666 0.649
Moderate-to-vigorous physical activity (min/week) 60 0; 540 60 0; 360 45 0; 540 0.609 0.582
Cortisol level –20 min prior to TSST onset (nmol/L) at baseline 3.2 1.2; 8.8 3.0 2.1; 8.8 4.3 1.2; 7.9 0.609 0.582
Cortisol level +20 min after completion of TSST (nmol/L) at baseline 5.2 1.1; 31.9 4.2 1.7; 31.9 8.1 1.1; 16.1 0.344 0.324
Overall cortisol response (AUCG) at baseline 380.8 114.5; 1225.6 299.2 157.4; 1225.6 521.0 114.8; 805.0 0.267 0.250
Cortisol level –20 min prior to TSST onset (nmol/L) at post-intervention 5.0 2.0; 13.9 4.7 2.0; 13.9 5.9 2.4; 9.1 0.687 0.661
Cortisol level + 20 min after completion of TSST (nmol/L) at post-intervention 4.7 2.2; 21.4 3.0 2.2; 16.1 5.2 2.5; 21.4 0.095 0.090
Overall cortisol response (AUCG) at post-intervention 392.3 200.2; 1252.0 351.1 200.2; 992.5 429.6 217.6; 1252.0 0.202 0.189
Categorial variables n % n % n % χ2 p
Sex (females) 13 52 6 43 7 64 1.07 0.302
Smoking status (smokers) 9 36 4 29 5 46 0.76 0.383
Educational background
Compulsory school 3 13 2 18 1 9 3.30 0.194
High school 14 64 5 46 9 82
Higher education 5 23 4 36 1 9
Diagnoses
F31 (Bipolar affective disorder) 1 4 1 7 0 0 0.90 0.625
F32 (Unipolar depressive episode) 10 40 5 36 5 46
F33 (Recurrent depressive disorder) 14 56 8 57 6 54
Notes. Normal distribution was tested with Kolmogorov-Smirnov test and Shapiro-Wilk test. BDI = Beck Depression Inventory. bpm = Beats per minute. BMI = Body Mass Index. AUCG
= Area under the curve with respect to ground. TSST = Trier Social Stress Test. M = Mean. SD = Standard deviation. Mdn = Median.
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3.3. Associations Between Potential Confounders and Stress Reactivity
As shown in Table 2, bivariate correlations and univariate ANOVAs revealed that none of the
potential confounders was significantly associated with the overall cortisol stress response during the
TSST (neither at baseline nor at post-intervention), as measured with AUCG. Therefore, none of these
factors were considered as a potential confounder in the subsequent repeated measures ANOVAs.
Table 2. Bivariate associations between potential confounders and stress reactivity (AUCG) at the
baseline data assessment and at post-intervention.
Bivariate Correlations with AUCG a
Metric Variables Baseline Post-Intervention
r/Rho p r/Rho p
Age b 0.09 0.671 −0.07 0.744
Depressive symptom severity (BDI) at baseline b 0.17 0.430 −0.17 0.419
Duration of current depressive episode c 0.155 0.458 −0.10 0.631
Number of prior depressive episodes c 0.11 0.601 −0.35 0.095
Age at onset of depression b −0.04 0.849 −0.05 0.817
Resting heart rate (bpm) b −0.22 0.301 0.14 0.514
Systolic blood pressure (mmHg) b 0.09 0.662 0.04 0.856
Diastolic blood pressure (mmHg) b 0.28 0.184 0.26 0.214
Height (cm) b 0.34 0.091 0.20 0.337
Weight (kg) b 0.33 0.104 0.22 0.300
BMI (kg/m2) b 0.27 0.185 0.17 0.410
Moderate-to-vigorous physical activity (min/week) c
Group differences in AUCG d
Categorial variables Baseline Post-Intervention
M SD F p η2 M SD F p η2
Sex 2.0 0.174 0.100 0.0 0.937 0.000
Males 538 312 413 135
Females 373 192 466 315
Smoking status 1.3 0.268 0.053 0.0 0.836 0.002
Smokers 506 223 425 201
Non-smokers 421 224 468 315
Educational background 0.1 0.942 0.006 0.1 0.939 0.007
Compulsory school 421 274 405 172
High school 467 197 480 300
Higher education 573 440 413 153
Diagnoses 0.6 0.537 0.055 0.1 0.909 0.009
F31 (Bipolar affective disorder) 720 0.0 440 0.0
F32 (Unipolar depressive episode) 443 340 433 142
F33 (Recurrent depressive disorder) 439 209 445 242
Notes. BDI = Beck Depression Inventory. BMI = Body Mass Index. AUCG = Area under the response curve
with respect to ground of salivary free cortisol. Bpm = Beats per minute. a Correlations based on logarithmized
AUCG scores. b Pearson’s correlations (r). c Spearman’s correlations (Rho). d F-, p- and η2-statistics are based on
logarithmized AUCG scores, M and SD are shown as non-logarithmized values.
3.4. Impact on Aerobic Exercise Training on Stress Reactivity
The results of the repeated measures ANOVAs, addressing the main study question, are displayed
in Table 3. No significant main and interaction effects occurred. As shown in Figure 2, no major
differences were found in cortisol response pattern at baseline and post-intervention between patients
of the intervention and control group.
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Table 3. Stress reactivity and depressive symptoms severity before and after six weeks of aerobic
exercise training.
Baseline Post-Intervention Time Group Time × GroupInteraction
Stress reactivityas
assessed via . . . n M SD M SD F p η
2 F p η2 F p η2
AUCG a in the . . . 0.1 0.798 0.003 1.7 0.209 0.068 0.0 0.860 0.001
Total sample 25 452 265 441 242
Intervention group 14 423 301 393 215
Control group 11 489 219 501 272
Depressive symptoms
as assessed via the . . . n M SD M SD F p η
2 F p η2 F p η2
BDI in the . . . 34.8 0.000 0.602 0.6 0.429 0.027 0.0 0.927 0.000
Total sample 25 26.4 8.6 15.7 11.1
Intervention group 14 27.6 10.0 17.1 12.5
Control group 11 24.9 6.6 14.0 9.2
Notes. AUCG = Area under the response curve with respect to ground. BDI = Beck Depression Inventory. a F-, p-
and η2-statistics are based on logarithmized AUCG scores, M and SD are shown as non-logarithmized values.
3.5. Correlations of Change Between Depressive Symptoms and Cortisol Response
Although not the focus of the present paper, Table 3 shows that depressive symptom severity
considerably decreased from baseline to post-intervention in both the intervention and the control
group. Accordingly, a strong main effect for time was found in the repeated measures ANOVA.
However, no significant time × group interaction was found in the present sample.
To examine the relationship between change in depressive symptom severity and change in cortisol
response, a Pearson’s correlation was computed (based on Kolmogorov–Smirnov and Shapiro–Wilk
tests, both change scores were normally distributed). The Pearson’s correlation between these variables
was r = 0.02, p = 0.944.
4. Discussion
The present study shows that six weeks of exercise training did not result in an altered pattern
of cortisol secretion in response to an acute psychosocial stressor among inpatients with MDD.
The findings are novel because this is the first study worldwide testing the validity of the cross-stressor
adaption (CSA) hypothesis in psychiatric patients [40]. Moreover, only one further intervention trial
exists in which the impact of an exercise training program was tested on the cortisol reactivity to
the TSST [42]. Changes in depressive symptom severity were not correlated with changes in cortisol
response to the TSST.
In contrast with the work of Klaperski et al. [42] with generally healthy, but physically inactive
employees, regular aerobic exercise training did not result in a blunted stress reactivity in our sample.
Figure 2 indicates that, in our sample, the cortisol response pattern remained nearly unchanged from
pre- to post-intervention in both participants assigned to the intervention and control condition. This is
remarkable as depressive symptom severity considerably decreased in both the intervention and
control group between the two assessment periods. A more detailed discussion regarding the effects of
the intervention on the primary outcome (depression symptom severity) is presented elsewhere [72].
Obviously, changes in depressive symptom severity and cortisol secretion during the TSST do not
change in parallel among patients with MDD undergoing inpatient treatment. While our findings
suggest that exercise training is more suited to impact on stress reactivity among healthy people, these
results do not allow too far-reaching conclusions. As highlighted in the introduction section, research
on the neurobiological mechanisms that explain the benefits of exercise training in individuals with
MDD is still in a very early stage [69], and research with neuroendocrine markers is sparse [54,68].
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Therefore, further research is needed to find out whether different effects occur if the training is
maintained over longer periods of time, and if patients with differing psychiatric disorders are assessed.
Beyond the main research question addressed in this paper, some further observations were
made. Our first observation was that as reported in the meta-analysis by Burke et al. [31], patients
with MDD tend to show a relatively non-responsive cortisol secretion pattern if exposed to the TSST.
This notion was supported in the present study. Although patients exhibited a significant increase in
free salivary cortisol concentration, on average, we found only a 1.6-fold increase from 20 min prior
to the TSST to peak, which is considerably lower than the response to socio-evaluative stressors in
healthy populations [25]. Moreover, the median cortisol concentrations at the peak (+20 min after
completion of the TSST) varied between 5.2 nmol/L (at the baseline data assessment) and 4.7 nmol/L
(at post-intervention) in the total sample. Again, this concentration is lower compared to studies with
healthy participants where group peak cortisol concentrations reached levels of >15 nmol/L [33,89].
Moreover, no evidence was found that patients’ non-responsiveness was due to heightened pre-stress
cortisol concentrations. As a putative mechanism for the blunted cortisol reactivity, Suzuki et al. [90]
pointed towards a downregulation of HPA axis activity among patients with MDD [91]. As highlighted
by McEwen and Stellar [92] and Juster et al. [93], exposure to chronic stress might lead to a repeated
overactivation and impairment of the HPA axis. This notion is in line with the fact that chronic
stress and critical life events play a major role in the development and maintenance of MDD [5,6].
This finding raises important questions regarding the interpretation of low cortisol responses. Thus,
while a low stress reactivity to acute laboratory stressors is generally regarded adaptive among healthy
participants [94,95], this is not necessarily the case among patients with MDD. In a model focussing on
brain structures involved in the regulation of stress reactivity, Lovallo [96] argued that a dysregulated
stress reactivity on the central nervous level (prefrontal cortex, limbic system, hypothalamus and brain
stem) will lead to poor behavioral homeostasis. Accordingly, Lovallo assumes that stress reactivity may
range from very low to very high and that both exaggerated and diminished stress reactivity may have
a negative impact on health, because both tendencies are indicative of a loss of homeostatic regulation.
Our second observation was that self-reported physical activity levels prior to hospitalization
were not associated with patients’ cortisol responses (either at the baseline data assessment or at
post-intervention). This is in contrast to previous results with healthy population, in which the CSA
hypothesis associated with physical activity and fitness was supported in about 60% of all studies [40].
The lack of a significant relationship can be attributed to various factors. First, it is difficult to detect
significant differences in a non-responsive sample. Second, most of the participants in our sample were
physically inactive or reported low physical activity levels. Thus, individual variability was limited in
the independent variable, as well.
Our third observation was that physical activity levels were relatively low among patients with
depressive disorders. In a previous meta-analysis, Schuch et al. [97] highlighted that among patients
with MDD, more than two thirds (68%) did not reach current levels of recommended physical activity
(≥150 min of MVPA per week). Moreover, Schuch et al. [97] showed that patients with MDD were
significantly more likely to miss MVPA recommendations than healthy controls. In the present study,
only 18% of the participants reached recommended MVPA standards. Given this background, it
is encouraging that sport and exercise training are increasingly used in Swiss psychiatric clinics as
an additional treatment approach [98], and that many MDD patients are sufficiently physically active
during their stay at the clinics [99]. Nevertheless, more systematic efforts are needed to increase
patients’ lifestyle physical activity sustainably [100,101], because the beneficial effects of exercise and
sport therapy may dissipate if the training is stopped after discharge from the clinic [102,103].
Finally, in contrast to previous studies [104], we did not find a significant association between
BMI and participants’ cortisol reactivity. Moreover, we did not find a link between age and stress
reactivity although previous studies suggested that the level of HPA axis dysregulation might increase
with age among people with depression [20,21]. We also did not observe a difference in cortisol stress
reactivity between women and men. While it is well established that women are more prone to
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develop depressive symptoms and MDD compared to men [105], studies examining sex differences in
stress reactivity have yielded equivocal findings [106], with men responding more strongly [107], less
strongly [108] or similarly [109] if compared to female participants. Chopra et al. [110] found in a study
comparing patients with chronic MDD with healthy controls that female patients exhibited a higher
reactivity, whereas a blunted reactivity was found in male patients. Nevertheless, the opposite pattern
of results was found in a study with depressed and non-depressed adolescents [80]. Thus, depressed
boys showed a higher cortisol reactivity than depressed girls, and the latter had a blunted cortisol
response in comparison to non-depressed girls.
The strengths of the present study can be summarized as follows. As mentioned previously,
this is the first study testing the CSA hypothesis in psychiatric patients, a population in which HPA
axis activity is often dysregulated. In the present study, all participants were diagnosed with MDD
according to ICD−10 definitions, were in-patients, and most of them reported moderate-to-severe levels
of depression. This is noteworthy, as Burke et al. [31] showed that cortisol reactivity is particularly
low in in-patients and in more severely depressed people. Moreover, few intervention studies have
been carried out so far to examine whether exercise training positively impacts on stress reactivity.
Another strength was that we first tested bivariate relationships with potential confounders to rule out
that these factors confound the association between self-reported physical activity and cortisol reactivity.
We used an established psychosocial stressor, which is known to trigger a stronger stress response
compared to other cognitive stressors due to its socio-evaluative character. Gender distribution was
almost equal in our sample. Finally, we systematically assessed energy expenditure in the intervention
group, showing that the compliance rate was high in the intervention group [71].
Despite these strengths, our findings need to be interpreted in light of several limitations. First,
the sample size was small. Thus, the low sample size did not allow for a consideration of further
moderating factors (such as sex, baseline physical activity levels, symptom severity, etc.). For instance,
we did not control atypical depression, a specific type of depression that has been associated with
stronger appetite, hyperphagia and hypersomnia, and a lower stimulation of the HPA axis [111].
We also acknowledge that our power calculation was based on the primary outcome (depressive
symptom severity) and not on cortisol response, although these are two different outcomes. Moreover,
a posteriori power analyses showed that with a repeated measures design (within-between interaction,
alpha error = 0.05, Power = 0.80, two groups, two measurements, correlations among repeated
measures of r = 0.35), we would have needed a total sample size of 258 participants to detect small
effects (f = 0.1) or 44 participants to detect moderate effects (f = 0.25). Because we only included
25 patients, our study was somewhat underpowered. Second, we were not able to control all influences
that may have an influence on individuals’ stress response (such as previous critical life events).
Moreover, for future studies with a repeated-measures design using two slightly different forms of the
TSST, it seems advisable to assign half of the group to the modified test at pre-intervention and then
switch tests at post-intervention to rule out the possibility that different tests produce different stress
reactions. Third, we also acknowledge that physical activity was based on participants’ self-reports
that might be negatively biased, especially since we studied a clinically depressed population. Fourth,
the intervention period was relatively short (six weeks). Thus, exercise training might have had
a stronger effect if carried out across a longer period of time. Fifth, a considerable number of eligible
participants were not willing to take part in the TSST, or dropped out from the baseline data assessment
to post-intervention, which may have entailed a selection and dropout bias. Nevertheless, we did not
find substantial differences between patients who declined participation, dropouts and patients who
volunteered for the TSST. Moreover, while we initially employed multiple imputation to substitute
missing values, this yielded highly improbable values, which we attributed to the small sample size.
We therefore proceed with a “per-protocol analysis” and did not carry out intention-to-treat analyses,
as originally foreseen in the study protocol [71]. Sixth, our study does not allow a direct comparison
with healthy controls. Such analyses may be important to more definitely establish whether the
validity of the CSA hypothesis holds in both psychiatric and healthy participants. Seventh, our sample
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included a fairly broad age-range. Eighth, we did not systematically assess the physical activity levels
of participants in the control group during the intervention period. Thus, we cannot exclude that
these patients also engaged in moderate-to-vigorous physical activities while they were hospitalized.
Ninth, we acknowledge that our control group also got some form of physical activity intervention
(standardized coordination and stretching activities). While the instructors made efforts to keep the
intensity level low, we did not monitor the intensity level systematically in this group. Moreover,
an additional “treatment as usual” (TAU) control group could have been helpful to further assess the
effect of the aerobic exercise intervention and the active control condition. Tenth, although we have
carried out a six-month follow-up assessment in order to assess the longer-term effects on the primary
and secondary outcomes, due to limited resources, we had to refrain from running the TSST a third time.
Finally, no generalization is possible to other stress reactivity indicators (e.g., cardiovascular, emotional)
and to stress reactivity in real-life conditions. The latter is important as researchers have shown that
cortisol reactivity following the TSST and in response to a real-life stressor are only weakly related.
In line with this notion, scholars assumed that stress reactions might be less strong in a laboratory
setting [112], because emotional involvement is limited during an experimental stressor test [113].
5. Conclusions
Patients with MDD tend to self-report insufficient physical activity levels and show a blunted
cortisol response pattern in following socio-evaluative stress. Therefore, systematic efforts are
needed to increase participants’ physical activity levels and foster their cardiorespiratory fitness and
cardiovascular health. More research is needed to find out which treatments are most efficient to
promote a normalization of HPA axis reactivity in patients with MDD. The present study suggests that
six weeks of aerobic exercise training are insufficient to impact on patients’ cortisol stress reactivity.
Nevertheless, since this was the first study on the CSA hypothesis with psychiatric patients, the
findings of our randomized controlled trial need to interpreted with caution until a broader empirical
evidence base exists.
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